Delivery Order SPE2DB22D2206-SPE2DB24FEZ55
Award Date 1/8/24
Potential Completion Date 1/30/24
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, with a potential value of $9,391.75 and a completion date of March 11, 2024. Amerisourcebergen Drug Corp is a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The $9,192.90 firm fixed price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has a completion date of January 19, 2024 and was awarded on December 27, 2023. No set-aside designation was used for this...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $4,348.80 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide 4562224597 units of HYPERRAB 300 UNIT/ML vials. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 19, 2023 through October 11, 2023. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $17,908 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of HYPERRAB 300 Unit/ML vial in 5ML quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical and medical supplies distributor. The $11,270.10 order is for HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty pharmaceutical product. The completion date is March 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- The Defense Logistics Agency awarded a $3,354.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial on November 17, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for HYPERRAB 300 Unit/ML Vial pharmaceutical product, with a ceiling value of $9,475.20. Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. The order is priced firm fixed price with no set-aside applied. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and holds a significant Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,263.36 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL Vials on January 14, 2026, with an ultimate completion date of February 5, 2026. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to the Place of Performance in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $8,668.70 delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vial 5mL on December 12, 2025, with an ultimate completion date of January 6, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,977.52 order is for the supply of HYPERRAB 300 UNIT/ML VIAL, a pharmaceutical product, with a completion date of February 13, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has a history of providing...